Overexpression of receptors, such as ACE2 due to IFN-I response or NRP-1 due to miR-148a downregulation, may create an action/reaction loop that enhances the infectious capacity of Omicron variants, explaining infectious breakthroughs in the days following anti-COVID-19 product administration. The gene discussed is ACE2; the disease is COVID-19.